PSA level, which is a commonly used biomarker for diagnosing prostatitis and PCa, has been reported to increase rapidly over time in African-American men relative to Caucasian-American men [104], thus suggesting genetic that epigenetic, and microbiome factors may be important drivers of racial/ethnic differences in serum PSA levels among men. The gene discussed is KLK3; the disease is urogenital neoplasm.